Skip to main content

Table 1 Influence of RAMP-O on composite milk SCC

From: Therapeutic effect of polysaccharide fraction of Atractylodis macrocephalae Koidz. in bovine subclinical mastitis

RAMP-O (mg) No. of cows Weeks post treatment
0 1 2 3
16 6 73.01 ± 10.05 65.79 ± 5.96 63.62 ± 17.94a* 54.65 ± 16.66a**
32 6 72.93 ± 18.42 62.31 ± 19.10 46.54 ± 25.14a 42.34 ± 21.30a*
48 6 71.48 ± 16.07 49.85 ± 23.49 45.01 ± 17.57A** 41.83 ± 14.81A*
Control 6 76.39 ± 14.38 77.20 ± 13.81 85.17 ± 12.15 77.47 ± 14.24
  1. SCC of composite milk in cows before and after subcutaneous injection of RAMP-O in the areas of supramammary lymph node (mean ± S.E. 104 cells/ml)
  2. aP < 0.05, AP < 0.01, compared with the control in the same time
  3. *P < 0.05, **P < 0.01, compared with pretreatment
  4. Pretreatment